01.04.2020 • News

Oqema has Entered into an Agency and Distribution Partnership with Chemada

The Oqema Group has entered into an exclusive agency and distribution...
The Oqema Group has entered into an exclusive agency and distribution partnership with Chemada. © totojang1977/Shutterstock

The Oqema Group has entered into an exclusive agency and distribution partnership with Chemada. Chemada Industries is a leading manufacturer that focuses on the research, development and production of fine chemicals for the pharmaceutical, agricultural and speciality chemicals industries. The Oqema Group will act as a European agent and distributor for the full range of Chemada’s high-quality brominated intermediates and brominating reagents, and also provide custom manufacturing based on other technologies to the Benelux countries, France, Germany, Denmark, Switzerland, the UK, the Czech Republic, Slovenia, the Baltic countries, Italy and Hungary.

James Berwick, Group Director of Speciality Chemicals, Oqema, comments, ‘As a leading distributor of speciality products in 21 European countries, the intermediate business of Chemada represents a strong addition to our portfolio. As the Oqema Group continues to build a wider chemical intermediate range, we are increasingly focused on bringing the leaders and innovators with a strong brand and market reputation into key areas of our portfolio. We are therefore very proud to be the exclusive distribution partner for the intermediate product range in major European countries, and our technical sales expert teams are ready to offer the Chemada range to our network.’

Eyal Azulay, CEO of Chemada Industries, adds, ‘We look forward to this new agency and distribution partnership with the Oqema Group. Oqema’s strong market and application experience, i.e. in the life-science and technical industries, and its proven performance as a value creator in the distribution markets, combined with its willingness and capability to represent the complete Chemada product range, are a good guarantee for a successful collaboration.’

Interview

Stability in Motion
Strategic Response to a Shifting Pharma Landscape

Stability in Motion

Stefan Oelrich, Member of the Board of Management and President Pharmaceuticals, Bayer, discusses navigating external volatility, reshaping its internal structures, and investing in future-ready capabilities to ensure sustainable growth.

Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences
Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.

most read

Photo

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.